Viewing Study NCT06806228


Ignite Creation Date: 2025-12-26 @ 11:11 AM
Ignite Modification Date: 2026-06-15 @ 3:30 AM
Study NCT ID: NCT06806228
Status: SUSPENDED
Last Update Posted: 2025-11-19
First Post: 2025-01-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Pilot Study to Evaluate the Anti-glioblastoma Effect of S-Gboxin in Standard Treatment of Glioblastoma/Diffuse Midline Glioma and Response to Treatment (Regardless of Mutation Status)
Sponsor: Petrov, Andrey
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: STM 0125-2G
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None UNKNOWN View